Therapeutic strategies in cancer biology and pathology (Registro nro. 207160)

MARC details
000 -LÍDER
fixed length control field 03477cam a2200661Ia 4500
001 - NÚMERO DE CONTROL
control field u380239
003 - IDENTIFICADOR DEL NÚMERO DE CONTROL
control field SIRSI
005 - FECHA Y HORA DE LA ULTIMA TRANSACCIÓN
control field 20160812084638.0
006 - ELEMENTOS DE LONGITUD FIJA - CARACTERÍSTICAS DE MATERIALES ADICIONALES - INFORMACIÓN GENERAL
fixed length control field m o d
007 - CAMPO FIJO DE DESCRIPCIÓN FIJA--INFORMACIÓN GENERAL
fixed length control field cr cnu---unuuu
008 - ELEMENTOS DE LONGITUD FIJA -- INFORMACIÓN GENERAL
fixed length control field 130810s2013 ne a ob 000 0 eng d
040 ## - FUENTE DE CATALOGACIÓN
Original cataloging agency EBLCP
Language of cataloging eng
Description conventions pn
Transcribing agency EBLCP
Modifying agency OCLCO
-- OPELS
-- IDEBK
-- NT
-- YDXCP
-- GZM
-- E7B
-- DEBSZ
-- WAU
-- GGVRL
-- OCLCQ
-- OCLCF
-- OCLCQ
-- COO
019 ## -
-- 859155094
-- 861477940
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS
International Standard Book Number 9780124165908
Qualifying information (electronic bk.)
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS
International Standard Book Number 0124165907
Qualifying information (electronic bk.)
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS
Canceled/invalid ISBN 9780124165700
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS
Canceled/invalid ISBN 0124165702
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DEBSZ
System control number 393956156
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NLGGC
System control number 369296702
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NZ1
System control number 15188286
050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO
Classification number RC268.4
082 04 - NÚMERO DE CLASIFICACIÓN DECIMAL DEWEY
Classification number 616.99/4
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library TEFA
100 1# - ASIENTO PRINCIPAL--NOMBRE PERSONAL
Personal name Sherbet, G. V.
Fuller form of name (Gajanan V.)
245 10 - MENCIÓN DE TITULO
Title Therapeutic strategies in cancer biology and pathology
Medium [recurso electrónico] /
Statement of responsibility, etc. Gajanan V. Sherbet.
260 ## - PUBLICACIÓN, DISTRIBUCIÓN, ETC. (PIE DE IMPRENTA)
Place of publication, distribution, etc. Amsterdam :
Name of publisher, distributor, etc. Elsevier,
Date of publication, distribution, etc. 2013.
300 ## - DESCRIPCIÓN FÍSICA
Extent 1 online resource (xxii, 288 pages) :
Other physical details illustrations.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - MENCIÓN DE SERIE
Series statement Elsevier insights
504 ## - NOTA DE BIBLIOGRAFÍA, ETC.
Bibliography, etc Includes bibliographical references.
505 0# - NOTA DE CONTENIDO
Formatted contents note RNA Interference in Genetic Regulation -- EMT Associated Gene Targeting -- Therapeutic Deployment of Metastasis-Associated Gene Function -- Genetic Determinants of Tumour and Metastasis Suppression -- Signalling and Transcription Regulators as Prospective Candidates in Cancer Therapy.
520 ## - NOTA DE RESUMEN, ETC.
Summary, etc. Currently, intensive effort is being directed toward the identification of molecular targets that can provide approaches to the development of novel therapeutic strategies in cancer management. This book focuses on metastasis-associated genes, metastasis promoter and suppressor genes, which relate specifically to behavioral alterations of cancer cells in epithelial mesenchymal transition, cancer stem cell maintenance and propagation, and to the acquisition of invasive and metastasis faculty. The function of these genes has implications for cell cycle regulation and cell proliferation and so constitute an essential element in cancer growth and dissemination.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
596 ## -
-- 19
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Cancer
General subdivision Molecular aspects.
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Cancer
General subdivision Genetic aspects.
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Cancer
General subdivision Treatment.
650 12 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Neoplasms
General subdivision genetics.
650 12 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Neoplasms
General subdivision therapy.
650 22 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Genetic Therapy
General subdivision methods.
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element HEALTH & FITNESS
General subdivision Diseases
-- General.
Source of heading or term bisacsh
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element MEDICAL
General subdivision Clinical Medicine.
Source of heading or term bisacsh
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element MEDICAL
General subdivision Diseases.
Source of heading or term bisacsh
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element MEDICAL
General subdivision Evidence-Based Medicine.
Source of heading or term bisacsh
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element MEDICAL
General subdivision Internal Medicine.
Source of heading or term bisacsh
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Cancer
General subdivision Genetic aspects.
Source of heading or term fast
Authority record control number (OCoLC)fst00845368
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Cancer
General subdivision Molecular aspects.
Source of heading or term fast
Authority record control number (OCoLC)fst00845397
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Cancer
General subdivision Treatment.
Source of heading or term fast
Authority record control number (OCoLC)fst00845538
655 #4 -
-- Electronic books.
655 #7 -
-- Electronic books.
-- local
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Sherbet, G.V. (Gajanan V.).
Title Therapeutic strategies in cancer biology and pathology.
Place, publisher, and date of publication London : Elsevier, [2013]
International Standard Book Number 9780124165700
Record control number (OCoLC)844308300
830 #0 - ASIENTO SECUNDARIO DE SERIE--TITULO UNIFORME
Uniform title Elsevier insights.
856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS
Public note Libro electrónico
Materials specified ScienceDirect
Uniform Resource Identifier <a href="http://148.231.10.114:2048/login?url=http://www.sciencedirect.com/science/book/9780124165700">http://148.231.10.114:2048/login?url=http://www.sciencedirect.com/science/book/9780124165700</a>
942 ## - TIPO DE MATERIAL (KOHA)
Koha item type Libro Electrónico
Existencias
Estado de retiro Fuente de clasificación Colección Ubicación permanente Ubicación actual Fecha de ingreso Total Checkouts Signatura topográfica Código de barras Date last seen Número de copia Tipo de material
    Colección de Libros Electrónicos Biblioteca Electrónica Biblioteca Electrónica     RC268.4 380239-2001 12/08/2016 1 Libro Electrónico

Con tecnología Koha